Company Aarti Drugs Limited

AARTIDRUGS

INE767A01016

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:46:29 11/07/2025 pm IST			5-day change	1st Jan Change
473.60 ^INR	-0.73%		-2.82%	+2.81%

07/05	Aarti Drugs Consolidated Net Profit Jumps in Fiscal Q4	MT
07/05	Aarti Drugs Limited, Q4 2025 Earnings Call, May 07, 2025

Business description: Aarti Drugs Limited

Aarti Drugs Limited is an India-based company, which is engaged in manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations. The Company operates through pharmaceuticals segment. The Company's APIs products include iprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole, ofloxacin, and others. Its specialty chemicals includes benzene sulphonyl chloride, methyl nicotinate, among others. Its pharma intermediates products include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, raloxifene and zolpidem. Its products under development include alpha lipoic acid, itraconazole, ticagrelor, and sitagliptin. The Company's subsidiaries include Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited, and Pinnacle Chile SPA.

Number of employees: 1,064

Sales by Activity: Aarti Drugs Limited

Fiscal Period: March	2020	2021	2022	2023	2024
Pharmaceuticals	1.81TCr	2.15TCr	2.49TCr	2.72TCr	2.53TCr

See all business segments

Geographical breakdown of sales: Aarti Drugs Limited

Fiscal Period: March	2020	2021	2022	2023	2024
India	1.18TCr	1.38TCr	1.57TCr	1.64TCr	1.67TCr
Out of India	622.94Cr	773.23Cr	922.33Cr	1.07TCr	862.88Cr

See all geographic segments

Executive Committee: Aarti Drugs Limited

Manager	Title	Age	Since
Prakash Moreshwar Patil CEO	Chief Executive Officer	77	01/06/2007
Adhish P. Patil DFI	Director of Finance/CFO	42	06/07/2012
Rushikesh Deole CMP	Compliance Officer	-	23/04/2019
Rashesh Chandrakant Gogri PRN	Corporate Officer/Principal	51	26/09/2014
Harshit Manilal Savla CEO	Chief Executive Officer	62	02/01/1987

See AARTI DRUGS LIMITED governance

Composition of the Board of Directors: Aarti Drugs Limited

Director	Title	Age	Since
Prakash Moreshwar Patil CHM	Chairman	77	01/04/2014
Harit Pragji Shah BRD	Director/Board Member	61	01/06/2007
Chandrakant V. Gogri CHM	Chairman	78	-
Uday Moreshwar Patil BRD	Director/Board Member	62	24/12/2009
Harshit Manilal Savla BRD	Director/Board Member	62	02/01/1987
Rashesh Chandrakant Gogri BRD	Director/Board Member	51	01/10/2012
Narendra Jagannath Salvi BRD	Director/Board Member	60	25/08/2020
Ankit Vikram Paleja BRD	Director/Board Member	41	13/10/2021
Bhaskar Narayan Thorat BRD	Director/Board Member	-	09/05/2022
Neha Rajen Gada BRD	Director/Board Member	49	09/05/2022

Composition of the Board of Directors

Shareholders: Aarti Drugs Limited

Name	Equities	%	Valuation
Prakash Moreshwar Patil 9.306 %	84,93,205	9.306 %	45 M ₹
DSP Asset Managers Pvt. Ltd. 7.995 %	72,97,442	7.995 %	39 M ₹
Harshit Manilal Savla 4.774 %	43,57,019	4.774 %	23 M ₹
Rashesh Chandrakant Gogri 4.681 %	42,71,964	4.681 %	23 M ₹
Priti Prakash Patil 4.435 %	40,47,669	4.435 %	22 M ₹

List of AARTI DRUGS LIMITED shareholders

Company details: Aarti Drugs Limited

Aarti Drugs Ltd.

Mahendra Industrial Estate Road No. 29, Sion (East)

400022, Mumbai

+91 22 2401 9025

http://www.aartidrugs.co.in

Group companies: Aarti Drugs Limited

Name	Category and Sector
Pinnacle Life Science Pvt Ltd. Pinnacle Life Science Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Aarti Drugs Ltd., Pinnacle Life Science Pvt Ltd. is an Indian company that manufactures and distributes tablets, capsules, syrups, suspension, ointments and creams. The company is based in Mumbai, India.	Pharmaceuticals: Major

See all subsidiaries

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
AARTI DRUGS LIMITED	-0.73%	-2.82%	-12.24%	+13.06%	51Cr
ELI LILLY AND COMPANY	+0.30%	+1.58%	-15.11%	+139.53%	71TCr
JOHNSON & JOHNSON	-0.50%	+0.57%	+4.81%	-12.03%	38TCr
ABBVIE INC.	-1.31%	+1.67%	+13.27%	+25.60%	34TCr
NOVO NORDISK A/S	-3.64%	-2.74%	-54.62%	+8.25%	31TCr
ROCHE HOLDING AG	-2.36%	-1.23%	+1.86%	-21.34%	26TCr
NOVARTIS AG	-3.00%	-1.93%	-3.07%	+15.94%	24TCr
ASTRAZENECA PLC	-1.66%	+1.10%	-13.64%	-6.31%	22TCr
MERCK & CO., INC.	-0.79%	+3.00%	-35.36%	-11.60%	21TCr
AMGEN INC.	-1.70%	-1.00%	-9.17%	+19.17%	16TCr
Average	-1.40%	+0.58%	-12.33%	+17.03%	28.18TCr
Weighted average by Cap.	-1.25%	+0.88%	-11.78%	+36.74%